Delivery Order SPE2DB22D2005-SPE2DB24FJQT3

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,695.03 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, with a period of performance through July 3, 2025. This delivery order is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a $6,867.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical supply product, with a period of performance through January 15, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a firm fixed price of $3,131.50 and a period of performance through April 18, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has a firm fixed price of $2,740.80 and a completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of pharmaceutical and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a firm fixed price of $1,349.19 and a period of performance through December 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a $1,368.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, which are pharmaceutical products used in the treatment of medical conditions. The contract is not set aside and is instead open to full and open competition. It has an ultimate completion date of May 27, 2025....
This federal contract award, valued at $1,757.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, with an ultimate completion date of January 17, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a $3,232.80 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,463,601 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes treatment medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a $5,374.01 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a period of performance through July 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of essential...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp for $1,084.27. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a completion date of June 7, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJQT3
    Delivery Order

This is a $1,795.38 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has a ceiling value of $1,795.38 and an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/29/24, 9:17 AM